HX575, Recombinant Human Epoetin Alfa, for the Treatment of Chemotherapy-Associated Symptomatic Anaemia in Patients with Solid Tumours

Publisher： Karger

E-ISSN： 2296-5262|32|4|168-174

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.4, 2009-03, pp. : 168-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 361-8609, Iss. 10, 2015-10 ,pp. : 877-881

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predicting the Hematopoietic Response to Recombinant Human Erythropoietin (Epoetin Alfa) in the Treatment of the Anemia of Cancer

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 46-53

Karger

Access to resources Recommend Favorite

Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia

By Tzekova Valentina   Mihaylov Georgi   Elezovic Ivo   Koytchev Rossen  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1689-1697

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Anaemia in Patients with Chronic Idiopathic Myelofibrosis

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Recombinant human epoetin beta in the treatment of renal anemia

By Del Vecchio Lucia   Cavalli Andrea   Pozzoni Pietro   Locatelli Francesco  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 91-98

Future Medicine

Access to resources Recommend Favorite